Hamid R Rassai, - Medicare General Surgery in Antioch, CA

Hamid R Rassai, is a medicare enrolled "Surgery" physician in Antioch, California. He went to Medical College Of Pennsylvania and graduated in 1995 and has 29 years of diverse experience with area of expertise as General Surgery. He is a member of the group practice Bass Medical Group and his current practice location is 3903 Lone Tree Way, Antioch, California. You can reach out to his office (for appointments etc.) via phone at (925) 757-0800.

Hamid R Rassai is licensed to practice in California (license number A060998) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013013218.

Contact Information

Hamid R Rassai,
3903 Lone Tree Way,
Antioch, CA 94509-6249
(925) 757-0800
(925) 757-2160



Physician's Profile

Full NameHamid R Rassai
GenderMale
SpecialityGeneral Surgery
Experience29 Years
Location3903 Lone Tree Way, Antioch, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Hamid R Rassai attended and graduated from Medical College Of Pennsylvania in 1995
  NPI Data:
  • NPI Number: 1013013218
  • Provider Enumeration Date: 09/15/2006
  • Last Update Date: 03/12/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 1850498742
  • Enrollment ID: I20070530000307

Medical Identifiers

Medical identifiers for Hamid R Rassai such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013013218NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208600000XSurgery A060998 (California)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Sutter Delta Medical CenterAntioch, CAHospital
John Muir Medical Center - Concord CampusConcord, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Bass Medical Group9032111281309

News Archive

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR).

Researchers discover new mechanism involving p53 to fight against aggressive cancers

Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers.

Cardiology researchers uncover new evidence that relates to increased risk of stroke

Cardiology researchers at The Queen Elizabeth Hospital have uncovered new evidence that relates to patients with new onset atrial fibrillation (AF) and their increased risk of stroke.

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Hamid R Rassai allows following entities to bill medicare on his behalf.
Entity NameJohn Muir Trauma Physicians Billing Service
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093864837
PECOS PAC ID: 3476542515
Enrollment ID: O20050420001452

News Archive

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR).

Researchers discover new mechanism involving p53 to fight against aggressive cancers

Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers.

Cardiology researchers uncover new evidence that relates to increased risk of stroke

Cardiology researchers at The Queen Elizabeth Hospital have uncovered new evidence that relates to patients with new onset atrial fibrillation (AF) and their increased risk of stroke.

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

Read more Medical News

› Verified 3 days ago

Entity NameSan Joaquin Faculty Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1225063761
PECOS PAC ID: 4082631395
Enrollment ID: O20051026000742

News Archive

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR).

Researchers discover new mechanism involving p53 to fight against aggressive cancers

Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers.

Cardiology researchers uncover new evidence that relates to increased risk of stroke

Cardiology researchers at The Queen Elizabeth Hospital have uncovered new evidence that relates to patients with new onset atrial fibrillation (AF) and their increased risk of stroke.

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

Read more Medical News

› Verified 3 days ago

Entity NameBass Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174253405
PECOS PAC ID: 9032111281
Enrollment ID: O20070201000181

News Archive

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR).

Researchers discover new mechanism involving p53 to fight against aggressive cancers

Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers.

Cardiology researchers uncover new evidence that relates to increased risk of stroke

Cardiology researchers at The Queen Elizabeth Hospital have uncovered new evidence that relates to patients with new onset atrial fibrillation (AF) and their increased risk of stroke.

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Hamid R Rassai is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Hamid R Rassai,
365 Lennon Ln Ste 250,
Walnut Creek, CA 94598-5915

Ph: (925) 627-3494
Hamid R Rassai,
3903 Lone Tree Way,
Antioch, CA 94509-6249

Ph: (925) 757-0800

News Archive

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR).

Researchers discover new mechanism involving p53 to fight against aggressive cancers

Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers.

Cardiology researchers uncover new evidence that relates to increased risk of stroke

Cardiology researchers at The Queen Elizabeth Hospital have uncovered new evidence that relates to patients with new onset atrial fibrillation (AF) and their increased risk of stroke.

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

Read more News

› Verified 3 days ago


Surgery Doctors in Antioch, CA

Phillip Willie Tan Polido, M.D
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 2350 Country Hills Dr Ste A, Antioch, CA 94509
Phone: 925-757-0800    Fax: 925-757-2160
Michael Lee Ditmars, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3903 Lone Tree Way, Suite 210, Antioch, CA 94509
Phone: 925-757-0800    Fax: 925-757-2160
Dr. Christopher Solis, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 4053 Lone Tree Way Ste 200, Antioch, CA 94531
Phone: 925-776-7725    
Abnet Amsalework Alemu, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2350 Country Hills Drive, Antioch, CA 94506
Phone: 612-508-2755    
Joseph M Brandel, M.D.
Surgery
Medicare: May Accept Medicare Assignments
Practice Location: 2350 Country Hills Dr, Antioch, CA 94509
Phone: 925-757-0800    Fax: 925-757-2160
Samuel K. Liu, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3901 Lone Tree Way, Antioch, CA 94509
Phone: 925-756-1192    Fax: 925-779-7220

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.